Heterogeneous phenotype of autoinflammatory disease in a patient with mutations in NOD2 and MEFV genes
Abstract
Background: Autoinflammatory diseases are a genetically heterogeneous group of conditions characterized by excessive activation of the innate immune system. They frequently present with overlapping features, particularly in cases of digenic or polygenic inheritance. The most common cause of autoinflammation arises from causative variants in the MEFV gene, responsible for familial Mediterranean fever. Clinical features include recurrent episodes of fever with serositis and amyloidosis. Individuals with variants in MEFV that present atypically with heterogeneous autoinflammatory features have also been described. Notably, gene modifiers of MEFV, such as NOD2 encoding an intracellular bacterial sensor, can result in more severe disease. NOD2 underlies a number of autoinflammatory and immunodeficiency conditions, including Blau syndrome. To date, Blau syndrome has not been described in the context of MEFV.
Aim: To expand the presentation and phenotype of autoinflammatory disease associated with defects in the NOD2 and MEFV genes.
Methods: A retrospective review of the patient’s chart was performed, including family history, medical history, immune laboratory evaluation, and genetics.
Results: We describe here a 68-year-old male with a remarkable medical history since childhood of skin rash, erythroderma, recurrent infections, autoinflammation, arthritis, uveitis, and malignancy. A significant family history of cancer and autoinflammation was noted. Genetic work-up involving a 17-gene autoinflammatory panel revealed 3 heterozygous variants of uncertain significance, 2 of which were present in the MEFV gene and one in the NOD2 gene. His features were consistent with an overlapping phenotype of Blau syndrome and atypical FMF.
Conclusion: Heterozygous variants in NOD2 and MEFV can result in a spectrum of autoinflammatory disorders with a heterogeneous phenotype. The NOD2 variant identified in our patient has not previously been associated with Blau syndrome.
Statement of Novelty: We describe a patient harbouring heterozygous mutations in the MEFV and NOD2 genes marked by recurrent childhood infections.
Formats available
You can view the full content in the following formats:
REFERENCES
Aksentijevich I., Torosyan Y., Samuels J., Centola M., Pras E., Chae J.J., Oddoux C., Wood G., Azzaro M.P., Palumbo G., Giustolisi R., Pras M., Ostrer H., and Kastner D.L. 1999. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am. J. Hum. Genet. 64: 949–962.
Berkun Y., Karban A., Padeh S., Pras E., Shinar Y., Lidar M., Livneh A., and Bujanover Y. 2012. NOD2/CARD15 Gene Mutations in Patients with Familial Mediterranean Fever. Semin Arthritis Rheum. 42: 84–88.
Booty M.G., Chae J.J., Masters S.L., Remmers E.F., Barham B., Le J.M., Barron K.S., Holland S.M., Kastner D.L., and Aksentijevich I. 2009. Familial mediterranean fever with a singleMEFVmutation: Where is the second hit? Arthritis Rheumatol. 60: 1851–1861.
Caruso R., Warner N., Inohara N., and Núñez G. 2014. NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease. Immunity, 41: 898–908.
Cazeneuve C., Sarkisian T., Pecheux C., Dervichian M., Nedelec B., Reinert P., Ayvazyan A., Kouyoumdjian J.C., Ajrapetyan H., Delpech M., Goossens M., Dode C., Grateau G., and Amselem S. 1999. MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65: 88–97.
Chae J.J., Cho Y.-H., Lee G.-S., Cheng J., Liu P.P., Feigenbaum L., Katz S.I., and Kastner D.L. 2011. Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1β Activation and Severe Autoinflammation in Mice. Immunity, 34: 755–768.
Chapman J.M., Onnie C.M., Prescott N.J., Fisher S.A., Mansfield J.C., Mathew C.G., Lewis C.M., Verzilli C.J., and Whittaker J.C. 2009. Searching for genotype-phenotype structure: using hierarchical log-linear models in Crohn disease. Am. J. Hum. Genet. 84: 178–187.
Christodoulou K., Wiskin A.E., Gibson J., Tapper W., Willis C., Afzal N.A., Upstill-Goddard R., Holloway J.W., Simpson M.A., Beattie R.M., Collins A., and Ennis S. 2013. Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut, 62: 977–984.
Hannan L.M., Ward J., Ebringer R., and Mcdonald C.F. 2012. Late presentation of familial Mediterranean fever associated with P369S/R408Q variant in the MEFV gene. Intern. Med. J. 42: 952–954.
Hugot J.-P., Chamaillard M., Zouali H., Lesage S., Cézard J.-P., Belaiche J., Almer S., Tysk C., O’Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.-F., Sahbatou M., and Thomas G. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature, 411: 599–603.
Kacar M., Pathak S., and Savic S. 2019. Hereditary systemic autoinflammatory diseases and Schnitzler’s syndrome. Rheumatology, 58: vi31–vi43.
King K., Sheikh M.F., Cuthbert A.P., Fisher S.A., Onnie C.M., Mirza M.M., Pattni R.C., Sanderson J., Forbes A., Mansfield J., Lewis C.M., Roberts R.G., and Mathew C.G. 2006. Mutation, selection, and evolution of the Crohn disease susceptibility geneCARD15. Human Mutation, 27: 44–54.
Martorana, D., Bonatti, F., Mozzoni, P., Vaglio, A., and Percesepe, A. 2017. Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations. Front. Immunol. 8.
Mcgonagle D. and Mcdermott M.F. 2006. A Proposed Classification of the Immunological Diseases. PLoS Med, 3: e297.
Miceli-Richard C., Lesage S., Rybojad M., Prieur A.-M., Manouvrier-Hanu S., Häfner R., Chamaillard M., Zouali H., Thomas G., and Hugot J.-P. 2001. CARD15 mutations in Blau syndrome. Nat. Gen. 29: 19–20.
Migita K., Agematsu K., Yazaki M., Nonaka F., Nakamura A., Toma T., Kishida D., Uehara R., Nakamura Y., Jiuchi Y., Masumoto J., Furukawa H., Ida H., Terai C., Nakashima Y., Kawakami A., Nakamura T., Eguchi K., Yasunami M., and Yachie A. 2014. Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine (Baltimore), 93: 158–164.
Mukherjee T., Hovingh E.S., Foerster E.G., Abdel-Nour M., Philpott D.J., and Girardin S.E. 2019. NOD1 and NOD2 in inflammation, immunity and disease. Arc. Biochem. Biophys. 670: 69–81.
Negroni A., Pierdomenico M., Cucchiara S., and Stronati L. 2018. NOD2 and inflammation: current insights. J. Inflam/ Res. 11: 49–60.
Nigrovic P.A., Lee P.Y., and Hoffman H.M. 2020. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach. J. Aller. Clin. Immunol. 146: 925–937.
Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.-P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nuñez G., and Cho J.H. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature, 411: 603–606.
Pathak S., Mcdermott M.F., and Savic S. 2017. Autoinflammatory diseases: update on classification diagnosis and management. J. Clin. Pathol. 70: 1–8.
Rood J.E. and Behrens E.M. 2022. Inherited Autoinflammatory Syndromes. Ann. Rev. Pathol. Mech. Disease, 17: 227–249.
Ryan J.G., Masters S.L., Booty M.G., Habal N., Alexander J.D., Barham B.K., Remmers E.F., Barron K.S., Kastner D.L., and Aksentijevich I. 2010. Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein. Ann. Rheum. Dis. 69: 1360–1363.
Simon A., Van Der Meer J.W.M., Veselý R., Myrdal U., Yoshimura K., Duys P., and Drenth J.P.H. 2006. Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology, 45: 269–273.
Steiner A., Harapas C.R., Masters S.L., and Davidson S. 2018. An Update on Autoinflammatory Diseases: Relopathies. Curr. Rheumatol. Rep. 20(7): 39.
Tangye S.G., Al-Herz W., Bousfiha A., Cunningham-Rundles C., Franco J.L., Holland S.M., Klein C., Morio T., Oksenhendler E., Picard C., Puel A., Puck J., Seppänen M.R.J., Somech R., Su H.C., Sullivan K.E., Torgerson T.R., and Meyts I. 2022. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J. Clin. Immunol. 42(7): 1473–1507.
Tunca M. and Ozdogan H. 2005. Molecular and Genetic Characteristics of Hereditary Autoinflammatory Diseases. Curr. Drug Target –Inflamm. Aller. 4: 77–80.
Yao Q., Li E., and Shen B. 2019. Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine. Autoimmunity, 52: 48–56.
Yao Q. and Shen B. 2017. A systematic analysis of treatment and outcomes of NOD2-associated autoinflammatory disease. Am. J. Med. 130: 365.e13–365.e18.
Yao Q., Shen M., and Gorevic P. 2021. NOD2 versus MEFV: Differential diagnosis of Yao syndrome and familial Mediterranean fever. Rheumatol. Immunol. Res. 2: 233–239.
Yao Q., Zhou L., Cusumano P., Bose N., Piliang M., Jayakar B., Su L.C., and Shen B. 2011. A new category of autoinflammatory disease associated with NOD2 gene mutations. Arthritis Res. Ther. 13: R148.
Yazdanyar S., Weischer M., and Nordestgaard B.G. 2009. Genotyping for NOD2 genetic variants and crohn disease: a metaanalysis. Clin. Chem. 55: 1950–1957.
Information & Authors
Information
Published In
LymphoSign Journal
Volume 9 • Number 4 • December 2022
Pages: 77 - 84
History
Received: 15 November 2022
Accepted: 24 November 2022
Accepted manuscript online: 28 November 2022
Copyright
© 2022.
Authors
Metrics & Citations
Metrics
Other Metrics
Citations
Cite As
Laura EdithAbrego Fuentes, IreneChair, PeterVadas, and Chaim M.Roifman. 2022. Heterogeneous phenotype of autoinflammatory disease in a patient with mutations in NOD2 and MEFV genes. LymphoSign Journal.
9(4): 77-84. https://doi.org/10.14785/lymphosign-2022-0013
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
There are no citations for this item
